1.48
+0.01(+0.68%)
Currency In USD
| Previous Close | 1.47 |
| Open | 1.49 |
| Day High | 1.6 |
| Day Low | 1.47 |
| 52-Week High | 4.1 |
| 52-Week Low | 1.45 |
| Volume | 81,069 |
| Average Volume | 99,111 |
| Market Cap | 167.29M |
| PE | -0.82 |
| EPS | -1.81 |
| Moving Average 50 Days | 2.02 |
| Moving Average 200 Days | 2.18 |
| Change | 0.01 |
If you invested $1000 in Waldencast plc (WALD) since IPO date, it would be worth $150.25 as of January 11, 2026 at a share price of $1.48. Whereas If you bought $1000 worth of Waldencast plc (WALD) shares 3 years ago, it would be worth $164.26 as of January 11, 2026 at a share price of $1.48.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
GlobeNewswire Inc.
Nov 16, 2025 6:02 AM GMT
Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentationNEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NAS
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
GlobeNewswire Inc.
Nov 14, 2025 10:05 PM GMT
NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it had sold its rights to the “Obagi” trademark in Japan to Rohto Ph
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
GlobeNewswire Inc.
Nov 12, 2025 12:33 PM GMT
First Half Fiscal 2025 Results and Q3 2025 Financial Results Expected to be Reported on November 24, 2025LONDON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, pro